Merck swings to loss as it books charge on $10.8 billion acquisition of Prometheus Biosciences By: MarketWatch August 01, 2023 at 11:15 AM EDT Merck's earnings were also hit by lower sales of its COVID antiviral Lagevrio. Read More >> Related Stocks: Merck & Co Pfizer
